Cargando…
CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma
BACKGROUND: The incidence and mortality of clear cell carcinoma of the kidney increases yearly. There are limited screening methods and advances in treating kidney renal clear cell carcinoma (KIRC). It is important to find new biomarkers to screen, diagnose and predict the prognosis of KIRC. Some st...
Autores principales: | Tian, Lv, Wang, Yiming, Zhang, Zhiyuan, Feng, Xuechao, Xiao, Fengjun, Zong, Minru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656955/ https://www.ncbi.nlm.nih.gov/pubmed/37980541 http://dx.doi.org/10.1186/s40001-023-01487-8 |
Ejemplares similares
-
LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Gong, Yun, et al.
Publicado: (2022) -
FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma
por: Gou, Hui, et al.
Publicado: (2023) -
C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023) -
Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023) -
Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)